Uncontrolled asthma in school-aged children-a nationwide specialist care study

Caroline Stridsman1, Øyvind Martinsen2,3, Stina Selberg1

  • 1Department of Public Health and Clinical Medicine, Division of Medicine/OLIN Unit, Umeå University, Umeå, Sweden.

Insights

Uncontrolled childhood asthma (UCA) affects 31% of pediatric patients and is linked to female sex, older age, and obesity. Many children with UCA are undertreated, indicating a need for better asthma management strategies.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Management
  • Public Health

Background:

  • Uncontrolled asthma (UCA) is a distinct condition from severe asthma, observable in children regardless of prescribed treatment intensity.
  • Identifying UCA in pediatric populations is crucial for effective asthma care and management strategies.

Purpose of the Study:

  • To characterize the prevalence and associated factors of uncontrolled childhood asthma (UCA) within pediatric specialist care settings.
  • To investigate the relationship between UCA and various demographic, clinical, and treatment parameters in children.

Main Methods:

  • A nationwide cross-sectional study involving 5497 children (aged 6-17 years) with asthma treated in Swedish outpatient clinics in 2019.
  • UCA was defined using criteria including Asthma Control Test score ≤19, ≥2 exacerbations annually, or FEV1 <80% predicted.
  • Treatment steps were categorized according to the Global Initiative for Asthma (GINA) guidelines (steps 1-5).

Main Results:

  • Uncontrolled asthma (UCA) was identified in 31% of the study cohort (n=1690).
  • Factors associated with UCA included female sex (OR=1.29), older age (OR=1.02), and obesity (OR=1.43).
  • UCA prevalence increased with higher GINA treatment steps (step 3: OR=1.28; steps 4-5: OR=1.32). Notably, 28% of children on lower treatment steps (1-2) had UCA, with higher exacerbation rates (24%) compared to UCA patients on higher steps (15%).

Conclusions:

  • Uncontrolled childhood asthma is common and associated with specific demographic factors and higher treatment steps.
  • A significant proportion of children with UCA are on lower treatment steps, suggesting potential undertreatment.
  • These findings highlight the need to reassess and optimize asthma management strategies in pediatric care to address UCA effectively, particularly in potentially undertreated populations.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396